{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:07:03Z","timestamp":1793333223959,"version":"4.5.0"},"reference-count":152,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2020,7,6]]},"DOI":"10.1021\/acs.molpharmaceut.0c00198","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:22:24Z","timestamp":1589228544000},"page":"2232-2244","source":"Crossref","is-referenced-by-count":68,"title":["Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies"],"prefix":"10.1021","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-1888","authenticated-orcid":true,"given":"Luke","family":"Schenck","sequence":"first","affiliation":[{"name":"Process Research and Development, Merck & Co. Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6314-2688","authenticated-orcid":true,"given":"Deniz","family":"Erdemir","sequence":"additional","affiliation":[{"name":"Drug Product Development, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick New Jersey 08903, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Saunders Gorka","sequence":"additional","affiliation":[{"name":"Pfizer Inc., 100 Route 206 North, Peapack, New Jersey 07977, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy M.","family":"Merritt","sequence":"additional","affiliation":[{"name":"Small Molecule Design and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46221, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Marziano","sequence":"additional","affiliation":[{"name":"Pfizer R&D UK Limited, Discovery Park, Ramsgate Road, Sandwich CT13 9NJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6555-937X","authenticated-orcid":true,"given":"Raimundo","family":"Ho","sequence":"additional","affiliation":[{"name":"Solid State Chemistry, AbbVie Inc., 1 North Waukegan Road, Chicago, Illinois 60064, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lee","sequence":"additional","affiliation":[{"name":"Chemical Development, Product Development and Supply, GlaxoSmithKline, Gunnelswood Road, Stevenage SG1 2NY, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bullard","sequence":"additional","affiliation":[{"name":"Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, Massachusetts 02210, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Boukerche","sequence":"additional","affiliation":[{"name":"Center of Excellence for Isolation and Separation Technologies, AbbVie Inc., 1 North Waukegan Road, Chicago, Illinois 60064, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ferguson","sequence":"additional","affiliation":[{"name":"SSPC, The SFI Centre for Pharmaceuticals, School of Chemical and Bioprocess Engineering, University College Dublin, Belifield, Dublin 4, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9706-8364","authenticated-orcid":true,"given":"Alastair J.","family":"Florence","sequence":"additional","affiliation":[{"name":"EPSRC Future Continuous Manufacturing and Advanced Crystallization Hub, CMAC, University of Strathclyde Glasgow, Glasgow, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117576, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-5334","authenticated-orcid":true,"given":"Changquan Calvin","family":"Sun","sequence":"additional","affiliation":[{"name":"Pharmaceutical Materials Science and Engineering Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1007\/s12247-015-9215-8"},{"key":"ref2\/cit2","unstructured":"Final Business Plan ICH Q13: Continuous Manufacturing\nfor Drug Substances\nand Drug Products.  International Council for\nHarmonisation of Technical Requirements for Pharmaceuticals for Human\nUse; ICH: Geneva, Switzerland, 2018."},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-018-1230-x"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118551"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/S0032-5910(02)00206-1"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1080\/03639040701377730"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.5b00479"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.9b00219"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.9b00053"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21063"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/cg400157y"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.8b01134"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.11.015"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118914"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201611914"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.05.007"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-004-9004-4"},{"key":"ref18\/cit18","unstructured":"New Drugs at FDA: CDER\u2019s New Molecular Entities and\nNew Therapeutic\nBiological Products; U.S. FDA, 2019."},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1039\/C4CE02403F"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1039\/C8CE01589A"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.6b00565"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.01.030"},{"key":"ref23\/cit23","unstructured":"Q7 Good Manufacturing Practice Guide for Active\nPharmacutical Ingredients; ICH, 2000."},{"key":"ref24\/cit24","unstructured":"Q7 Implementation Working\nGroup ICH Q7 Guideline: Good Manufacturing\nPractice Guide for Active Pharmaceutical Ingredients Questions and\nAnswers; ICH, 2015."},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9455-5"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23206"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.01.026"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.59.2.0006"},{"key":"ref29\/cit29","unstructured":"CHMP Assessment Report: Zelboraf; EMA\/CHMP: London, UK, 2012."},{"key":"ref30\/cit30","unstructured":"CHMP Assessment Report:\nTybost; EMA\/CHMP: London, UK, 2013."},{"key":"ref31\/cit31","volume-title":"Quality Working Party questions and answers on API mix","year":"2016"},{"key":"ref32\/cit32","unstructured":"Madurawe, R. D. An FDA Perspective on Expanding Continuous Manufacturing to the Drug Substance -Drug Product Interface.  ISPE Annual Meeting; ISPE, Las Vegas, 2019."},{"key":"ref33\/cit33","unstructured":"CHMP Assessment Report:\nVanlfyta; EMA\/CHMP: Amsterdam, Netherlands, 2019."},{"key":"ref34\/cit34","volume-title":"Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry","year":"2018"},{"key":"ref35\/cit35","first-page":"90","volume":"22","author":"Meyer R. F.","year":"2019","journal-title":"American Pharmaceutical Review"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1080\/17461390500402657"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.01.021"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.4103\/0973-8398.41569"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1390-3"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600780118"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.2174\/15672018113109990046"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2012.662508"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.8b00204"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2018.1483386"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23425"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.08.031"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.07.001"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.01.009"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.09.008"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-011-0518-2"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.9b00354"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1021\/cg4012982"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.8b00432"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.6b01701"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1021\/la503179t"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.08.009"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1021\/la3041083"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.7b00297"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1021\/cg2010858"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1021\/acs.cgd.7b01336"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1021\/bp9600492"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2004.12.001"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1039\/c0ce00419g"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(85)90024-9"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1021\/cg060293t"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600590512"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(00)00610-4"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.3109\/03639048809152019"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1021\/cg049646j"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1021\/cg060885b"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(94)00216-R"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.06.014"},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.1039\/C4CE02164A"},{"key":"ref74\/cit74","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(94)90257-7"},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1021\/cg7007599"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrysgro.2013.04.006"},{"key":"ref77\/cit77","doi-asserted-by":"publisher","DOI":"10.1016\/j.apt.2011.11.002"},{"key":"ref78\/cit78","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9468-0"},{"key":"ref79\/cit79","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1387-y"},{"key":"ref80\/cit80","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24442"},{"key":"ref81\/cit81","doi-asserted-by":"publisher","DOI":"10.1021\/cg300325p"},{"key":"ref82\/cit82","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24493"},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.7b00145"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-009-9187-4"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2005.08.013"},{"key":"ref86\/cit86","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(94)90219-4"},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.1088\/1361-651X\/ab234a"},{"key":"ref88\/cit88","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20672"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1021\/cg501084a"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2014.03.032"},{"key":"ref91\/cit91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ces.2007.10.020"},{"key":"ref92\/cit92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2011.12.044"},{"key":"ref93\/cit93","doi-asserted-by":"publisher","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W"},{"key":"ref94\/cit94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.06.016"},{"key":"ref95\/cit95","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2011.03.011"},{"key":"ref96\/cit96","doi-asserted-by":"publisher","DOI":"10.1021\/cg901270x"},{"key":"ref97\/cit97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.02.046"},{"key":"ref98\/cit98","doi-asserted-by":"publisher","DOI":"10.1021\/cg301830u"},{"key":"ref99\/cit99","doi-asserted-by":"publisher","DOI":"10.1080\/10837450802012869"},{"key":"ref100\/cit100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.01.049"},{"key":"ref101\/cit101","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2014.913323"},{"key":"ref102\/cit102","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201104763"},{"key":"ref103\/cit103","doi-asserted-by":"publisher","DOI":"10.1039\/C5CE01148E"},{"key":"ref104\/cit104","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22657"},{"key":"ref105\/cit105","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.03.005"},{"key":"ref106\/cit106","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.06.019"},{"key":"ref107\/cit107","first-page":"12","volume":"19","author":"Timmins P.","year":"2013","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"ref108\/cit108","unstructured":"Koziara, J. M.; Menning, M. M.; Strickley, R. G.; Yu, R.; Kearney, B. P.; Mathias, A. A. Use of solid carrier particles to improve the processability of a pharmaceutical agent. U.S. Patent US10039718B2, 2018."},{"key":"ref109\/cit109","doi-asserted-by":"publisher","DOI":"10.1039\/B913879J"},{"key":"ref110\/cit110","doi-asserted-by":"publisher","DOI":"10.1039\/c2cc30959a"},{"key":"ref111\/cit111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.06.038"},{"key":"ref112\/cit112","doi-asserted-by":"publisher","DOI":"10.1006\/jcis.2002.8408"},{"key":"ref113\/cit113","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2018.12.021"},{"key":"ref114\/cit114","doi-asserted-by":"publisher","DOI":"10.1021\/op500262q"},{"key":"ref115\/cit115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.01.007"},{"key":"ref116\/cit116","doi-asserted-by":"publisher","DOI":"10.1002\/aic.14209"},{"key":"ref117\/cit117","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.12.016"},{"key":"ref118\/cit118","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201600266"},{"key":"ref119\/cit119","doi-asserted-by":"publisher","DOI":"10.1021\/cg500250e"},{"key":"ref120\/cit120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.05.006"},{"key":"ref121\/cit121","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600590409"},{"key":"ref122\/cit122","doi-asserted-by":"publisher","DOI":"10.1021\/ed082p575"},{"key":"ref123\/cit123","volume":"251","author":"Gehris A.","year":"2016","journal-title":"Abstracts of Papers of the American Chemical Society"},{"key":"ref124\/cit124","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2018.1562467"},{"key":"ref125\/cit125","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.03.028"},{"key":"ref126\/cit126","doi-asserted-by":"publisher","DOI":"10.1006\/jcis.2000.7167"},{"key":"ref127\/cit127","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2005.04.032"},{"key":"ref128\/cit128","doi-asserted-by":"publisher","DOI":"10.1126\/science.263.5154.1720"},{"key":"ref129\/cit129","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21998"},{"key":"ref130\/cit130","doi-asserted-by":"publisher","DOI":"10.1021\/mp300529a"},{"key":"ref131\/cit131","unstructured":"Young, M. W.; Gogos, C. G.; Yang, J.; R, D.; Zhu, L.; Bonnett, P.; Schepige, W. Continuous high-speed coating of finely ground particulates. U.S. Patent US8252370B1, 2005."},{"key":"ref132\/cit132","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22677"},{"key":"ref133\/cit133","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2011.06.008"},{"key":"ref134\/cit134","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23301"},{"key":"ref135\/cit135","doi-asserted-by":"publisher","DOI":"10.1016\/j.powtec.2013.08.031"},{"key":"ref136\/cit136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.04.002"},{"key":"ref137\/cit137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.11.068"},{"key":"ref138\/cit138","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.01.021"},{"key":"ref139\/cit139","doi-asserted-by":"publisher","DOI":"10.1021\/cr900056b"},{"key":"ref140\/cit140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.04.031"},{"key":"ref141\/cit141","doi-asserted-by":"publisher","DOI":"10.1039\/C7NR03261G"},{"key":"ref142\/cit142","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.9b00247"},{"key":"ref143\/cit143","unstructured":"Current Good\nManufacturing Practice in Manufacturing, Processing,\nPackaging or Holding of Drugs; General; U.S.\nFDA, 2019."},{"key":"ref144\/cit144","unstructured":"Glossary\nof Quality Terms; Government of\nCanada, 2018."},{"key":"ref145\/cit145","unstructured":"WHO.  Good manufacturing practices for pharmaceutical products:\nmain principles; World Health Organization, 2014; Vol. 986, pp 78\u2013135."},{"key":"ref146\/cit146","unstructured":"Q1A(R2) Stability Testing\nof New Drug Substances and Products; ICH, 2003."},{"key":"ref152\/cit152","unstructured":"Current Good Manufacturing\nPractice for Finished Pharmaceuticals.  Code\nof Federal Regulations, Part 211, Title 21, 2019."},{"key":"ref147\/cit147","unstructured":"Note for Guidance on Start of Shelf-Life of the\nFinished Dosage Form\n(Annex to Note for Guidance on the Manufacture of the Finished Dosage\nForm); European Agency for the Evaluation\nof Medicinal Products: London, 2001."},{"key":"ref148\/cit148","unstructured":"Quality (Chemistry and\nManufacturing) Guidance: New Drug Submissions\n(NDSs) and Abbreviated New Drug Submissions (ANDSs); Government of Canada, 2018."},{"key":"ref149\/cit149","unstructured":"Q11 Development and manufacture of drug substances (chemical\nentities\nand biotechnological\/biological entities); ICH, 2012."},{"key":"ref150\/cit150","unstructured":"Q6A\nSpecifications: Test Procedures and Acceptance Criteria for New\nDrug Substances and New Drug Products: Chemical Substances; ICH, 1999."},{"key":"ref151\/cit151","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21552"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.0c00198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T18:09:48Z","timestamp":1681754988000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.0c00198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":152,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7,6]]}},"alternative-id":["10.1021\/acs.molpharmaceut.0c00198"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00198","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]}}}